SCHEMBL6136381

SCHEMBL6136381

CCOC(=O)CCNCc1ccc(OCc2ccccc2)c(OC)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.64
APP P05067 1/20 0.57
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
PKM P14618 1/20 0.56
LMNA P02545 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
HTT P42858 3/20 0.55
KDM4E B2RXH2 2/20 0.55
NPY1R P25929 1/20 0.55
NPY2R P49146 1/20 0.55
KMT2A Q03164 1/20 0.55
MTNR1A P48039 2/20 0.55
MTNR1B P49286 2/20 0.55
HTR1A P08908 1/20 0.55
HTR7 P34969 1/20 0.55
HTR6 P50406 1/20 0.55
ALDH1A1 P00352 2/20 0.54
SLC2A1 P11166 1/20 0.54
NLRP3 Q96P20 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16839021 0.89 FFAR4 (0.58) BCHESMN1; SMN2KDM4EKMT2ASLC2A1
SCHEMBL6136228 0.87 HDAC3 (0.58) SMN1; SMN2KDM4EKMT2AALDH1A1
SCHEMBL16839011 0.87 CD274 (0.52) BCHELMNASMN1; SMN2HTTKDM4E
SCHEMBL5881099 0.85 APP (0.73) BCHEAPPNPC1RAB9APKM
SCHEMBL5113589 0.84 BCHE (0.69) BCHENPC1RAB9APKMLMNA
SCHEMBL6136380 0.84 L3MBTL1 (0.61) BCHELMNASMN1; SMN2HTTKDM4E
SCHEMBL9724394 0.83 APP (0.62) APPNPC1RAB9APKMSMN1; SMN2
SCHEMBL25292445 0.83 SLC2A1 (0.52) BCHELMNASMN1; SMN2HTTKDM4E
SCHEMBL6136444 0.82 LMNA (0.54) LMNASMN1; SMN2KDM4EKMT2AALDH1A1
Hydrochloric Acid SCHEMBL4949263 0.82 BCHE (0.77) BCHENPC1RAB9APKMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042279-B1 SUBSTITUTED BETA-ALANINES AVENTIS PHARMA LTD (GB) 2005-03-02 EP disclosed
US-6352977-B1 ALANINE WITH PRODRUGS AVENTIS PHARMA LIMITED (GB) 2002-03-05 US disclosed
EP-1042279-A1 SUBSTITUTED BETA-ALANINES Aventis Pharma Limited (GB) 2000-10-11 EP disclosed
WO-1999033789-A1 SUBSTITUTED β-ALANINES AVENTIS PHARMA LIMITED (GB) 1999-07-08 WO disclosed